Identification of potential protein interactors of Lrrk2
- PMID: 17400507
- PMCID: PMC2970619
- DOI: 10.1016/j.parkreldis.2007.01.008
Identification of potential protein interactors of Lrrk2
Abstract
Pathogenic substitutions in the Lrrk2 protein have been shown to be an important cause of both familial and sporadic parkinsonism. The molecular pathway involved in Lrrk2 dopaminergic neuron degeneration remains elusive. Employing a combination of Lrrk2-mediated protein precipitation and tandem mass spectrometry, we identified 14 potential Lrrk2 binding partners. The majority of these interactions may be subgrouped into three functional cellular pathways: (i) chaperone-mediated response, (ii) proteins associated with the cytoskeleton and trafficking and (iii) phosphorylation and kinase activity. Future investigation of these candidates is now warranted and may help resolve the pathomechanism behind Lrrk2 neurodegeneration.
Figures
Similar articles
-
A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease.Neuroscience. 2007 Jul 29;147(4):1047-58. doi: 10.1016/j.neuroscience.2007.05.027. Epub 2007 Jul 3. Neuroscience. 2007. PMID: 17611037
-
A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics.Mol Cell Proteomics. 2011 Jan;10(1):M110.001172. doi: 10.1074/mcp.M110.001172. Epub 2010 Sep 27. Mol Cell Proteomics. 2011. PMID: 20876399 Free PMC article.
-
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease.Biochemistry. 2007 Feb 6;46(5):1380-8. doi: 10.1021/bi061960m. Biochemistry. 2007. PMID: 17260967
-
Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2).Hum Mutat. 2014 Apr;35(4):395-412. doi: 10.1002/humu.22515. Epub 2014 Feb 24. Hum Mutat. 2014. PMID: 24470158 Review.
-
[Clinical molecular genetics for PARK8 (LRRK2)].Brain Nerve. 2007 Aug;59(8):839-50. Brain Nerve. 2007. PMID: 17713120 Review. Japanese.
Cited by
-
Cellular processes associated with LRRK2 function and dysfunction.FEBS J. 2015 Aug;282(15):2806-26. doi: 10.1111/febs.13305. Epub 2015 May 9. FEBS J. 2015. PMID: 25899482 Free PMC article. Review.
-
Molecular chaperones in Parkinson's disease--present and future.J Parkinsons Dis. 2011;1(4):299-320. J Parkinsons Dis. 2011. PMID: 22279517 Free PMC article. Review.
-
Pharmacological therapy in Parkinson's disease: focus on neuroprotection.CNS Neurosci Ther. 2011 Oct;17(5):345-67. doi: 10.1111/j.1755-5949.2010.00150.x. Epub 2010 Apr 23. CNS Neurosci Ther. 2011. PMID: 20438581 Free PMC article. Review.
-
LRRK2 in Parkinson's disease: in vivo models and approaches for understanding pathogenic roles.FEBS J. 2009 Nov;276(22):6445-54. doi: 10.1111/j.1742-4658.2009.07343.x. Epub 2009 Oct 5. FEBS J. 2009. PMID: 19804414 Free PMC article. Review.
-
Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease.Mech Ageing Dev. 2010 Mar;131(3):210-4. doi: 10.1016/j.mad.2010.01.009. Epub 2010 Feb 6. Mech Ageing Dev. 2010. PMID: 20144646 Free PMC article.
References
-
- Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet. 2006;7:306–318. - PubMed
-
- Marin I. The Parkinson Disease Gene LRRK2: Evolutionary and Structural Insights. Mol Biol Evol. 2006;23:2423–2433. - PubMed
-
- Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA. LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci. 2006;29:286–293. - PubMed
-
- Gloeckner CJ, Kinkl N, Schumacher A, Braun RJ, O'Neill E, Meitinger T, et al. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet. 2006;15:223–232. - PubMed
-
- Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, et al. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis. 2006;23:329–341. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases